It is learnt that 1,50,000 doses of Covisheild vaccine, manufactured by the Serum Institute of India (SII), were sent to Bhutan and 1,00,000 doses reached Maldives as part of India's grant assistance

In the first phase, which started from January 13, the airline transported a total of 7,20,000 doses to five destinations.

Peak power demand met grew at 1.7 per cent in September, 3.4 per cent in October, 3.5 per cent in November and 7.3 per cent in December

Bharat Biotech is developing the intranasal vaccine in partnership with the Washington University School of Medicine and US-based vaccine maker Ocugen

Coronavirus vaccination drive: Dr RS Sharma, chairman of the empowered group on COVID-19 vaccination said the average vaccination sessions of 100 were allowed per site but in some centres fewer people were turning up

India COVID-19 immunisation: On Tuesday, 1,77,368 beneficiaries were vaccinated till 6 pm through 3,800 sessions, Union Health Ministry said, adding the final report for the day will be complied by late in the night

The industry has also sought reduction in basic custom duty and correction of inverted duty structure on critical raw materials for aluminium industry value chain like aluminium fluoride and coal tar pitch

Government think tank NITI Aayog's members along with top medical experts have requested the people eligible for vaccination not to fall for rumours on safety. They added that minor adverse effects are common and should not deter people from inoculation

The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) on Tuesday recommended Bharat Biotech's intranasal vaccine for conducting phase 1 clinical trials for the coronavirus

Countries including Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles will be the first recipients of the COVID-19 vaccine shipments out of India

COVID-19 vaccination in Punjab: The reason for low vaccination rate was healthcare workers' concerns over the vaccine's safety along with a glitch in the CoWIN digital platform

Russia began testing EpiVacCorona, which is being developed by Siberia's Vector Institute, in November

The Serum Institute of India (SII) said one should not get the jab's shot if he/she had a severe allegoric reaction following a previous dose of Covishield

As many as 3,600 healthcare workers were vaccinated against coronavirus in Delhi on January 18, very less than the opening day of the nationwide COVID-19 immunisation drive; Indian auto market leader Maruti Suzuki has increased the prices on account of higher input costs; Indians may soon find job offers from Japan in sectors like healthcare, construction, aviation, food services, agriculture. Watch this and more on News Blast.Also Read: Don't take vaccine if you have these conditions; Bharat Biotech releases advisory

According to experts, people have adopted a \"wait and watch\" approach which has resulted in low turnout at vaccination centres

Close on the heels of some adverse incidents being reported, a detailed fact sheet released by Bharat Biotech says those with bleeding disorders or on blood thinners should avoid taking the shot for now

Global economic outlook remains highly uncertain: IMF chief The head of the International Monetary Fund said on Monday the global economic outlook remained highly uncertain given the coronavirus pandemic, and a growing divergence between rich and poor countries required the IMF to find more resources. IMF Managing Director Kristalina Georgieva said a new allocation of the IMF's own currency, Special Drawing Rights, would help give countries more fiscal space to tackle the health crisis and ...

The COVAX scheme -- led by the WHO and GAVI vaccine alliance -- is due to start rolling out vaccines to poor and middle-income countries in February, with 2 of 3 billion doses expected to be delivered this year

COVID-19 immunisation in Delhi: The sharp drop in immunisations comes after 51 adverse events following immunization - one severe and 50 minor cases were reported from Delhi on Saturday

Fitch has downgraded Delhi Airport because of the sharp drop in footfall on the back of pandemic-induced travel restrictions, weaker earnings, and net debt-EBITDAR ratio increasing to 10